Liquid Biopsy of Head and Neck Cancer Patients in Blood and Saliva

NCT05122507 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-04-12

No results posted yet for this study

Summary

Prospective study for therapy monitoring of locally advanced and metastatic head and neck cancer patients by detection of circulating tumor nucleic acids in peripheral blood and saliva

Conditions

Sponsors & Collaborators

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Irina Kerle, MD · Technical University of Munich

  • Markus Wirth, MD · Technical University of Munich

  • Christof Winter, MD, PhD · Technical University of Munich

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-08
Primary Completion
2023-04-30
Completion
2023-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05122507 on ClinicalTrials.gov